Physician profile
Solomon C Yang
NPI 1366714016
$1,733.12
in general payments reported to CMS, 2019-2025
13 companies · $55.04 in 2025
The $55.04 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $582 · 2021: $103 · 2023: $154 · 2025: $55.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $544.34 | 2019-2020 | |
| Amgen INC. | $277.97 | 2019-2021 | |
| Abbott Laboratories | $236.74 | 2019-2025 | Amplatzer Amulet, Mitraclip |
| Medtronic, INC. | $154.00 | 2023 | Attain Command + Surevalve, Abre |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.71 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $111.07 | 2019 | |
| Elutia, INC. | $83.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $72.82 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $56.06 | 2019 | |
| Sanofi-Aventis U.S. LLC | $37.64 | 2019 | |
| Medtronic Vascular, INC. | $17.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.84 | 2019 | |
| Amarin Pharma, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.